| LINE ITEM (USD / %) | FY 2025
FILED 2026-02-28 | FY 2024
FILED 2025-02-28 | FY 2023
FILED 2024-02-29 |
|---|---|---|---|
| Revenue (Total Sales) | $9.14B | $10.21B | $9.96B |
| YoY Revenue Growth % | -10.5% | +2.5% | — |
| Gross Profit | $4.71B | $5.31B | — |
| Gross Margin % | 51.6% | 52.1% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $2.72B | $354.9M | $3.17B |
| Operating Margin % | 29.8% | 3.5% | 31.8% |
| Net Income (GAAP) | $1.69B | -$81.4M | $1.73B |
| EBITDA (Normalized) | $3.42B | $1.33B | $3.53B |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $2.67B | $3.15B | $2.78B |
| Capital Expenditures (CapEx) | $875.0M | $1.21B | $448.3M |
| Free Cash Flow (FCF) | $1.79B | $1.94B | $2.33B |
| FCF Margin % | 19.6% | 19.0% | 23.4% |
| Return on Invested Capital (ROIC %) | 12.0% | 1.6% | 34.2% |
| Cash & Short-Term Equivalents | $152.4M | $73.7M | — |
| Total Debt (Short + Long Term) | $10.29B | $10.19B | $2.84B |
| Total Stockholders' Equity | $7.71B | $7.82B | $5.82B |